908 Devices Inc.
MASS7.380USD
-0.420-5.38%
Close 11/07, 16:00（ET）Quotes delayed by 15 min
266.10MMarket Cap
LossP/E TTM
More Details of 908 Devices Inc. Company
908 Devices Inc. offers a suite of purpose-built handheld and desktop mass spectrometry (Mass Spec) devices for the point of need chemical and biochemical analysis. The Company's Mass Spec devices are used at the point of need to interrogate unknown and invisible materials and provide answers to address problems in life sciences research, bioprocessing, industrial biotechnology, forensics and adjacent markets. Its products include MX908, Rebel, ZipChip, Maven and Maverick. MX908 is a handheld, battery-powered, Mass Spec device designed for the analysis of solid, liquid, vapor and aerosol materials of unknown identity. MX908 is a multi-purpose device utilized by a spectrum of user segments for a variety of forensic field applications, including chemical, explosive, priority drug and hazardous materials operations, detecting materials at the trace level. The Rebel is a small desktop analyzer providing real-time information on the extracellular environment in bioprocesses.
908 Devices Inc. Info
Ticker SymbolMASS
Company name908 Devices Inc
IPO dateDec 18, 2020
CEODr. Kevin J. Knopp, Ph.D.
Number of employees246
Security typeOrdinary Share
Fiscal year-endDec 18
Address645 Summer Street
CityBOSTON
Stock exchangeNASDAQ Global Market Consolidated
CountryUnited States of America
Postal code02210
Phone19787294478
Websitehttps://908devices.com/
Ticker SymbolMASS
IPO dateDec 18, 2020
CEODr. Kevin J. Knopp, Ph.D.
Company Executives of 908 Devices Inc.
Name
Name/Position
Position
Shareholding
Change
Dr. Kevin J. Knopp, Ph.D.
Dr. Kevin J. Knopp, Ph.D.
President, Chief Executive Officer, Co-Founder, Director
President, Chief Executive Officer, Co-Founder, Director
1.26M
+2.43%
Dr. Christopher D. Brown, Ph.D.
Dr. Christopher D. Brown, Ph.D.
Co-Founder, Director
Co-Founder, Director
962.12K
--
Mr. Mark Spoto
Mr. Mark Spoto
Independent Director
Independent Director
74.33K
+18.05%
Mr. Fenel M. Eloi
Mr. Fenel M. Eloi
Independent Director
Independent Director
26.81K
+73.55%
Mr. Keith L. Crandell
Mr. Keith L. Crandell
Independent Director
Independent Director
25.29K
+81.60%
Ms. Michele M. Leonhart
Ms. Michele M. Leonhart
Independent Director
Independent Director
6.49K
--
Dr. Brandi C. Vann, Ph.D.
Dr. Brandi C. Vann, Ph.D.
Independent Director
Independent Director
--
--
Jon Frattaroli
Jon Frattaroli
Vice President - Strategy
Vice President - Strategy
--
--
Mr. E. Kevin Hrusovsky
Mr. E. Kevin Hrusovsky
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ms. Barbara Russo
Ms. Barbara Russo
Vice President - Marketing and Corporate Communications
Vice President - Marketing and Corporate Communications
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Dr. Kevin J. Knopp, Ph.D.
Dr. Kevin J. Knopp, Ph.D.
President, Chief Executive Officer, Co-Founder, Director
President, Chief Executive Officer, Co-Founder, Director
1.26M
+2.43%
Dr. Christopher D. Brown, Ph.D.
Dr. Christopher D. Brown, Ph.D.
Co-Founder, Director
Co-Founder, Director
962.12K
--
Mr. Mark Spoto
Mr. Mark Spoto
Independent Director
Independent Director
74.33K
+18.05%
Mr. Fenel M. Eloi
Mr. Fenel M. Eloi
Independent Director
Independent Director
26.81K
+73.55%
Mr. Keith L. Crandell
Mr. Keith L. Crandell
Independent Director
Independent Director
25.29K
+81.60%
Ms. Michele M. Leonhart
Ms. Michele M. Leonhart
Independent Director
Independent Director
6.49K
--
Revenue Breakdown
Currency: USDUpdated: Mon, Oct 6
Currency: USDUpdated: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
By BusinessUSD
Name
Revenue
Proportion
Device sales revenue
8.28M
63.54%
Consumables and service revenue
4.73M
36.31%
License and contract revenue
20.00K
0.15%
By RegionUSD
Name
Revenue
Proportion
United States
10.93M
83.85%
Europe,Middle East & Africa
1.37M
10.48%
Asia Pacific
671.00K
5.15%
Americas other
68.00K
0.52%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Device sales revenue
8.28M
63.54%
Consumables and service revenue
4.73M
36.31%
License and contract revenue
20.00K
0.15%
Shareholding Stats
Updated: Sun, Aug 17
Updated: Sun, Aug 17
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
ARCH Venture Partners
15.87%
AWM Investment Company, Inc.
14.41%
State Street Investment Management (US)
6.34%
ARK Investment Management LLC
5.41%
BlackRock Institutional Trust Company, N.A.
4.48%
Other
53.49%
Shareholders
Shareholders
Proportion
ARCH Venture Partners
15.87%
AWM Investment Company, Inc.
14.41%
State Street Investment Management (US)
6.34%
ARK Investment Management LLC
5.41%
BlackRock Institutional Trust Company, N.A.
4.48%
Other
53.49%
Shareholder Types
Shareholders
Proportion
Investment Advisor/Hedge Fund
38.89%
Investment Advisor
22.60%
Venture Capital
15.88%
Individual Investor
8.36%
Hedge Fund
3.22%
Research Firm
2.16%
Pension Fund
0.17%
Bank and Trust
0.09%
Insurance Company
0.03%
Other
8.60%
Institutional Shareholding
Updated: Sun, Oct 5
Updated: Sun, Oct 5
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
223
29.97M
83.04%
-3.25M
2025Q2
226
29.86M
82.76%
-3.27M
2025Q1
235
29.47M
83.22%
+34.34K
2024Q4
242
25.43M
73.04%
-4.66M
2024Q3
246
27.53M
79.50%
-3.86M
2024Q2
248
28.48M
83.77%
-4.52M
2024Q1
241
29.63M
90.49%
-5.18M
2023Q4
255
31.02M
95.84%
-3.81M
2023Q3
261
30.10M
93.52%
-5.15M
2023Q2
268
30.29M
94.48%
-6.54M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
ARCH Venture Partners
5.73M
15.87%
--
--
Apr 17, 2025
AWM Investment Company, Inc.
5.20M
14.41%
--
--
Jun 30, 2025
State Street Investment Management (US)
2.29M
6.34%
+1.82M
+388.85%
Jun 30, 2025
ARK Investment Management LLC
2.65M
7.34%
-251.07K
-8.66%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
1.62M
4.48%
+115.41K
+7.69%
Jun 30, 2025
The Vanguard Group, Inc.
1.43M
3.97%
+68.94K
+5.06%
Jun 30, 2025
Knopp (Kevin J)
1.26M
3.5%
+30.00K
+2.43%
May 15, 2025
GM Advisory Group, LLC
1.17M
3.23%
+1.17M
--
Jun 30, 2025
First Light Asset Management, LLC
1.07M
2.96%
-633.48K
-37.24%
Jun 30, 2025
Brown (Christopher D)
962.12K
2.67%
--
--
Apr 17, 2025
View more
Related ETFs
Updated: Thu, Nov 6
Updated: Thu, Nov 6
Name
Proportion
ARK Genomic Revolution ETF
1.49%
SPDR S&P Kensho Future Security ETF
1.32%
SPDR S&P Kensho New Economies Composite ETF
0.57%
iShares Micro-Cap ETF
0.05%
Avantis US Small Cap Equity ETF
0.03%
iShares Russell 2000 ETF
0.01%
Proshares Ultra Russell 2000
0.01%
Global X Russell 2000 ETF
0.01%
iShares Russell 2000 Growth ETF
0.01%
ProShares UltraPro Russell2000
0.01%
View more
ARK Genomic Revolution ETF
Proportion1.49%
SPDR S&P Kensho Future Security ETF
Proportion1.32%
SPDR S&P Kensho New Economies Composite ETF
Proportion0.57%
iShares Micro-Cap ETF
Proportion0.05%
Avantis US Small Cap Equity ETF
Proportion0.03%
iShares Russell 2000 ETF
Proportion0.01%
Proshares Ultra Russell 2000
Proportion0.01%
Global X Russell 2000 ETF
Proportion0.01%
iShares Russell 2000 Growth ETF
Proportion0.01%
ProShares UltraPro Russell2000
Proportion0.01%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
